Table 3.
The correlation between ATBF1 protein levels and clinicopathological parameters
| Characteristics | ATBF1 WI(SE) | |||||
|---|---|---|---|---|---|---|
| BC029653 | P value | D1-120 | P value | 3B1 | P value | |
| Tumor size | ||||||
| ≤2(41) | 177.3(11.3) | 0.02* | 117.1(8.8) | 0.32 | 151.0(13.7) | 0.001* |
| >2(39) | 139.5(11.6) | 105.9(6.8) | 91.0(9.6) | |||
| LNM | ||||||
| Yes(36) | 157.2(10.6) | 0.86 | 110.6.4(7.4) | 0.73 | 109.4(10.8) | 0.22 |
| No(44) | 160.2(12.5) | 113.4(8.3) | 131.8(13.7) | |||
| Grade | ||||||
| I-II(51) | 184.3(9.9) | <0.001* | 127.1(6.4) | <0.001* | 138.6(12.7) | 0.002* |
| III(29) | 114.3(10.7) | 82.1(7.4) | 90.3(8.5) | |||
| ER | ||||||
| (-)(27) | 143.3(13.9) | 0.16 | 105.6(9.8) | 0.44 | 102.2(15.5) | 0.16 |
| (+)(53) | 168.1(10.2) | 114.7(6.9) | 128.5(10.4) | |||
| PR | ||||||
| (-)(30) | 135.0(13.5) | 0.03* | 99.7(8.4) | 0.10 | 104.7(13.4) | 0.17 |
| (+)(50) | 173.2(10.1) | 118.8(7.3) | 129.8(11.7) | |||
| HER2 | ||||||
| (-)(35) | 150.6(14.4) | 0.40 | 110.0(8.8) | 0.80 | 116.6(13.7) | 0.45 |
| (+)(45) | 165.3(9.6) | 112.9(7.3) | 130.2(11.8) | |||
*P < 0.05